Porphobilinogen synthase (PBGS) catalyzes the condensation of two molecules of 5-aminolevulinic acid (ALA), an essential step in tetrapyrrole biosynthesis. 4-Oxosebacic acid (4-OSA) and 4,7-dioxosebacic acid (4,7-DOSA) are bisubstrate reaction intermediate analogs for PBGS. We show that 4-OSA is an active sitedirected irreversible inhibitor for Escherichia coli PBGS, whereas human, pea, Pseudomonas aeruginosa, and Bradyrhizobium japonicum PBGS are insensitive to inhibition by 4-OSA. Some variants of human PBGS (engineered to resemble E. coli PBGS) have increased sensitivity to inactivation by 4-OSA, suggesting a structural basis for the specificity. The specificity of 4-OSA as a PBGS inhibitor is significantly narrower than that of 4,7-DOSA. Comparison of the crystal structures for E. coli PBGS inactivated by 4-OSA versus 4,7-DOSA shows significant variation in the half of the inhibitor that mimics the second substrate molecule (A-side ALA). Compensatory changes occur in the structure of the active site lid, which suggests that similar changes normally occur to accommodate numerous hybridization changes that must occur at C3 of A-side ALA during the PBGS-catalyzed reaction. A comparison of these with other PBGS structures identifies highly conserved active site water molecules, which are isolated from bulk solvent and implicated as proton acceptors in the PBGScatalyzed reaction.
viable enzyme target for the development of pharmaceuticals or agricultural agents. The PBGS protein, which is highly conserved in both sequence and structure (1) , catalyzes an early essential step in the biosynthesis of the tetrapyrrole cofactors such as heme and chlorophyll (Fig. 1A) . Despite the fact that much is known about the PBGS structure, the sequence of bond-making and bond-breaking events that follow formation of the ternary complex of PBGS with the two substrate molecules is the subject of active discussion (2) (3) (4) (5) . Based on an extensive phylogenetic variation in the number and kinds of metal ions used for catalytic and/or allosteric roles, it is possible that the order of chemical events in the enzymecatalyzed reaction mechanism may not be phylogenetically conserved. In order to probe the mechanism, 4,7-dioxosebacic acid (4,7-DOSA) and 4-oxosebacic acid (4-OSA), illustrated in Fig.  1B , were designed and found to act as suicide substrates for Escherichia coli PBGS (6) . These inhibitors mimic an addition product intermediate in which the first bond formed between the two 5-aminolevulinic acid (ALA) substrate molecules creates a carbinolamine that dehydrates to a Schiff base (6) . More recently, a strong species-selective inhibition of PBGS by 4,7-DOSA has been correlated with an active site variation in metal ion usage (3). Here we have characterized a very different species selectivity for 4-OSA inhibition of PBGS and provide a 1.9-Å crystal structure of 4-OSA-inhibited E. coli PBGS. This structure was compared with an improved 1.7-Å crystal structure of E. coli PBGS inhibited by 4,7-DOSA and with analogous structures of these inhibitors bound to yeast PBGS (for which, however, there are no kinetic inhibition data) (5) .
EXPERIMENTAL PROCEDURES
Materials-Most chemicals and buffers were obtained from Fisher or Sigma in the purest available form. 2-Mercaptoethanol (␤ME) from Fluka (Buchs, Switzerland) was vacuum-distilled prior to use. 4-OSA and 4,7-DOSA were synthesized and tested (as described in Ref. 6 ). All of the PBGS enzymes used in this study were cloned and expressed in E. coli, and purification and detailed characterization has been described previously (7) (8) (9) (10) (11) (12) . Human PBGS was the C162A variant of the natural N59 isozyme, and it has kinetic properties closely resembling the wild type (13) . Human PBGS mutants characterized with 4-OSA were N59/C162A/H131A/C223A (called MinusZnA) (13) and two new chimeric proteins (Hs⌬ALK and HsEclid) containing portions of the E. coli PBGS active site lid. The chimeric proteins were prepared from the plasmid encoding wild type human PBGS variant N59/C162A by the QuikChange method of mutagenesis. The sense strand primers were CCGTTCCGTGATGCGCTAAGTCAGCATTAAAAGGCGACCGCCGC-TGC for Hs⌬ALK and CCGTTCCGTGAAGCTGCTGGGTCAGCCTTA-AAAGGCGACCGCAAAGCTATCAG for HsEclid.
Activity Assays for PBGS-The enzyme assay measures the formation of porphobilinogen from ALA. The assay conditions at optimal pH and with a full complement of required and allosteric metal ions in the standard 5-min assay procedure for each of the five PBGS were performed as described previously (3). Human mutants MinusZnA, Hs⌬ALK, and HsEclid were assayed in the same fashion as the wild type. To ensure reliable A 555 values, assays of low specific activity mutants used a 30-min incubation with substrate. Enzyme concentrations were measured with Coomassie Plus protein assay reagent (Pierce) relative to a standard curve prepared with bovine serum albumin.
Inhibition of PBGS by 4-OSA-The five species of PBGS (1 M subunit) were preincubated under optimal assay conditions for 10 min at 37°C prior to the addition of 4-OSA over the concentration range of 10 M to 3 mM; preincubation was allowed to proceed for various times ranging from 90 min to 22 h at 37°C before initiating the formation of porphobilinogen by addition of ALA-HCl to a final concentration of 10 mM. Porphobilinogen formation was allowed to proceed for 5 min. For E. coli PBGS, 4-OSA inhibition data were fitted to the equation v/v o ϭ 1/(1ϩ([I]/IC 50 )) (14) using the program SigmaPlot (SPSS, Chicago, IL). For other species of PBGS the apparent IC 50 values for 4-OSA were well above millimolar concentrations and the 10 M-3 mM inhibition data could not be fit well. In these cases a simple direct comparison of the five species used a 4-OSA concentration of 3 mM and a 24-h enzyme/inhibitor incubation time prior to the addition of ALA.
Crystallization of E. coli PBGS Complexed with 4,7-DOSA and 4-OSA and Structure Solution-Crystallizations were carried out with both 4-OSA and 4,7-DOSA as described previously for 4,7-DOSA (3). In both cases, E. coli PBGS (9 mg ml Ϫ1 in 50 mM Tris-HCl, pH 8.0, 10 mM ␤ME, 20 M ZnCl 2 , 10 mM MgCl 2 ) was incubated for 24 h at 37°C with a 16-fold molar excess of the inhibitor (ϳ4 mM) prior to setting up the crystallization trays. An equal volume of clarified protein was mixed with reservoir buffer containing 1-6% polyethylene glycol 3350, 10% glycerol, 0.1 M Tris-HCl, pH 8.5, and 0.02% sodium azide. The crystals with a diamond-like shape appeared in 1-3 days, and the largest crystals grew to their final size (up to 0.6 ϫ 0.6 ϫ 0.3 mm 3 ) in approximately 2 weeks. Cryoprotection was carried out by transferring a crystal to reservoir solutions containing 17, 23, and 30% glycerol, respectively (3 min in each solution), and the crystal was flash-frozen in a liquid nitrogen vapor. X-ray diffraction data for both complexes were collected from one crystal at 100 K using a QUANTUM-4 CCD detector mounted at synchrotron beamline X9B at Brookhaven National Synchrotron Light Source facility. The data sets consisted of 180 frames chosen to cover at least one asymmetric unit with each frame corresponding to 0.5°oscillation exposed for 35 s. Crystals belong to a tetragonal system, space group, P42 1 2; unit cell parameters, a ϭ b ϭ 129.0 Å, and c ϭ 142.8 Å with two molecules per asymmetric unit. Diffraction intensities were processed with the HKL2000 suite of programs (15) , resulting in final data sets with R merge (I) ϭ 5.1 and 5.6% for 126,253 and 92,714 independent reflections and with completeness of 95.7 and 99.8% for the 40 -1.7 and 40 -1.9 Å resolution range for 4,7-DOSA and 4-OSA complexes, respectively.
Because the crystals were in both cases isomorphous to that of E. coli PBGS complexed with 4,7-DOSA (PDB entry 1I8J), rigid body refinement of the PBGS dimer against the corresponding diffraction data was sufficient to properly orient the protein model in the respective crystal unit cell. Refinement was carried out with program package CNS (16) with weak non-crystallographic symmetry restraints corresponding to weight 25. Model building was performed with program O (17) . The final models included one dimer of PBGS molecule complexed with two respective inhibitor molecules, 498 and 433 water molecules for 4,7-DOSA and 4-OSA, respectively, as well as two Zn 2ϩ and two Mg 2ϩ ions. Five glycerol molecules were found in the 4-OSA structure. The crystallographic R-factors were 19.5 and 20.6%, R (free) parameters were 24.3 and 26.3% for the 1.7-and 1.9-Å resolution data, and the RMS deviations for bond lengths and bond angles were 0.018 Å and 1.8°for 4,7-DOSA and 0.019 Å and 2.0°for 4-OSA, respectively. The coordinates have been deposited in the Protein Data Bank with the PDB codes 1L6S and 1L6Y for immediate release.
RESULTS

Kinetic Evaluation of the Inhibition of PBGS Enzymes by
4-OSA-The inactivation of PBGS by 4,7-DOSA was shown previously to be dependent both upon the concentration of the inhibitor and the preincubation time of the inhibitor and enzyme prior to addition of substrate (3). This is also true for 4-OSA, which was a less potent inactivator than 4,7-DOSA. Fig. 2A illustrates the time and concentration dependence for the interaction of 4-OSA with E. coli PBGS using enzyme/ inhibitor incubation times of 94 min and 16 h and 4-OSA concentrations from 10 M to 3 mM. For comparison we also included data from a comparable 100-min incubation of E. coli PBGS in which 4,7-DOSA was the inhibitor (3). These data indicate that 4-OSA is far less potent against E. coli PBGS than is 4,7-DOSA, consistent with prior reports (6) . Using the approximation of Copeland et al. (14) , the IC 50 values for E. coli PBGS inhibition by 4-OSA at 94 min and 16 h are 0.57 Ϯ 0.06 mM and 0.22 Ϯ 0.01 mM, respectively. The IC 50 for 4,7-DOSA at 100 min of incubation with E. coli PBGS is 0.039 Ϯ 0.002 mM. The reduced sensitivity to 4-OSA relative to 4,7-DOSA is also true for human, Bradyrhizobium japonicum, Pseudomonas aeruginosa, and Pisum sativum (pea) PBGS, where a similar experiment showed marginal if any inactivation by 4-OSA across the range of 10 M to 3 mM 4-OSA. To compare the five species, Fig. 2B illustrates a 24-h preincubation of 3 mM 4-OSA with all five PBGS and shows a high selectivity for inactivation of E. coli PBGS. The control reactions wherein inhibitor was omitted did not lose any significant activity.
Evaluation of 4-OSA with Mutant Forms of Human PBGS-
The high selectivity of 4-OSA inactivation for E. coli PBGS is in sharp contrast to the species selectivity of inactivation by 4,7-DOSA (3). The latter showed a marked preference for the Zn 2ϩ -utilizing PBGS and was highly effective against human PBGS, which contains two different types of Zn 2ϩ binding sites. In that case, evaluation of an active human PBGS mutant (MinusZnA) that lacked the nonessential Zn 2ϩ showed reduced sensitivity to 4,7-DOSA. Of the five species evaluated, only human and E. coli PBGS use a catalytic Zn 2ϩ . Because the number and types of Zn 2ϩ sites are a significantly different between human and E. coli PBGS, this MinusZnA human PBGS was also evaluated with 4-OSA, and the results are included in Fig. 2C . Consistent with the notion that MinusZnA is more like E. coli PBGS, MinusZnA retains only ϳ65% activity after a 22-h incubation with 3 mM 4-OSA. Thus, MinusZnA is significantly more sensitive to inactivation by 4-OSA than is 
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human PBGS, but it remains far less sensitive than E. coli PBGS.
In search for the structural basis for the high selectivity of 4-OSA against E. coli PBGS, we compared the known structures (and sequences) of the PBGS to define unique features of E. coli PBGS. One significant variable feature in the PBGS family of proteins is the length and sequence of the active site lid. Based on the E. coli PBGS crystal structure, the lid is defined as the stretch from Ala 196 to Gln 219 . The lid includes all of the residues in this region that are found to be disordered in PBGS structures 1AW5, 1B4K, and 1E51. Fig. 3A shows a structure-based sequence alignment of the active site lid of human, yeast, E. coli, P. aeruginosa, B. japonicum, and P. sativum PBGS, which is different from previously published sequence-based alignments. Fig. 3B shows a color-coded structural overlay of the lid region from PBGS corresponding to PDB codes 1E51 (human), 1YLV (yeast), 1I8J (E. coli), and 1B4K (P. aeruginosa). E. coli PBGS is unique among those tested with 4-OSA in that it has the shortest lid sequence. To evaluate the significance of this variable, we created, prepared, and characterized two chimeric "lid-switch" PBGS based on human PBGS using portions of the E. coli lid sequence.
The minimal lid switch chimeric protein contains the small portion of the E. coli lid that varies in backbone structure. The sequence of this variant, called Hs⌬ALK, is included in Fig. 3A .
Hs⌬ALK is an active PBGS with a specific activity of ϳ4% of wild type human PBGS and a normal K m value. Purified Hs⌬ALK contains 3.5 Zn 2ϩ /octamer. As predicted from its increased sequence similarity with E. coli PBGS, Hs⌬ALK has increased sensitivity to inhibition by 4-OSA (see Fig. 2C ). A less predictable result was observed when a larger portion of the lid sequence was switched. The human PBGS variant HsEclid contains the E. coli PBGS lid sequence from Arg 204 to Gln 219 (E. coli numbering) as illustrated in Fig. 3A . HsEclid is also an active PBGS with a specific activity of ϳ12% of wild type human PBGS and a normal K m value. HsEclid was found to purify with 4.5 Zn 2ϩ /octamer. Inconsistent with other human PBGS variants that are designed to resemble E. coli PBGS, HsEclid is insensitive to inhibition by 4-OSA (see Fig. 2C ). The human PBGS variant MinusZnA, whose behavior with 4-OSA is described above, is included in Fig. 3 because one of the mutations (C223A) is in this active site lid region. The Zn 2ϩ stoichiometry of Hs⌬ALK and HsEclid suggests that these human PBGS variants retain the property of half-site reactivity, a kinetic property that is well established for human PBGS but not for E. coli PBGS.
E. coli PBGS Crystal Structures with 4-OSA and 4,7-DOSA-
The PBGS all share a common octameric structure with two monomers forming a dimer around either the noncrystallographic or crystallographic 2-fold symmetry axis and four such dimers forming a PBGS octamer around the 4-fold symmetry axis. Each monomer/subunit forms an ␣␤-barrel, the center of which holds the active site residues, while an Nterminal arm that varies in length between species is mutually wrapped around the neighboring subunit forming a compact dimeric structure. The N-terminal arms are involved in extensive subunit interactions within and between dimers. Some PBGS crystal structures show an individual subunit as the asymmetric crystallographic unit, and others (such as those presented here) show a dimer as the asymmetric unit. A variety of data have been interpreted to indicate that an oligomeric structure is required for activity (see Ref. 7) . Each active site region is confined to one subunit and isolated from bulk solvent by a lid. The 4,7-DOSA-containing E. coli PBGS was the first structure to show that the lid-closed configuration involves extensive hydrogen bonding with the carboxyl group of the A-side ALA molecule, which makes up the acetyl half of porphobilinogen (see Fig. 1A and below) (3) . The structure is consistent with the notion that P-side ALA, which makes up the propionyl half of the product, binds first and that the A-side ALA binds second (see Refs. 18 and 19 ). Similar to other ␣␤- . B, inactivation of a family of wild type PBGS enzymes by 3 mM 4-OSA using a fixed 24-h inhibitor/enzyme incubation time prior to activity assay. The species are E. coli (Ec), human (Hs), B. japonicum (Bj), P. aeruginosa (Pa), and P. sativum L. (Ps). For these determinations, the protein concentrations were all at 1 M subunit. C, inactivation of mutant or chimeric PBGS by 3 mM 4-OSA using a 24-h enzyme/inhibitor incubation time. The bars correspond to E. coli (Ec), human (Hs), human MinusZnA (ϪZnA), Hs⌬ALK, and HsEclid. barrel enzymes, the ordering and disordering of the active site lid appears to be essential for substrate binding, isolation of the active site from bulk solvent, and product release. The current structures better define these lid motions. The lid residues seen to interact with active site ligands presented here and elsewhere are denoted in Fig. 3 .
Here we present the crystal structures of E. coli PBGS that has been inactivated by 4-OSA and of another one that has been inactivated by 4,7-DOSA. The latter structure is the same complex that we already published (PDB code 1I8J); however, this time resolution of the diffraction data was extended to 1.7 Å so that we were able to locate 183 extra water molecules, clarify that both Cys 133A and Cys 133B are adducted with ␤-mercaptoethanol (see below), and generally provide a more accurate structural description of the protein and the inhibitors. A major new observation based on this structure is a significant variation in the position of the inhibitor half that mimics A-side ALA. Such a result has not been reported for the comparable complex of 4-OSA with yeast PBGS (5) . Similar to the complex of 4,7-DOSA-inhibited PBGS, the 4-OSA-inhibited E. coli PBGS asymmetric unit contains a dimer, and each subunit of the 4-OSA complex contains one inhibitor molecule, one Zn 2ϩ bound at the active site, and one Mg 2ϩ bound at the allosteric site (Fig. 4) . Unlike the 4,7-DOSA-inhibited PBGS, the 4-OSA complex can form only one Schiff base linkage between each inhibitor and PBGS subunit; this linkage is observed. The RMS deviation between the C␣ atoms of the two monomers forming a non-crystallographic dimer is 0.25 Å, whereas the RMS deviation between the 4,7-DOSA-and 4-OSA-inhibited PBGS dimers is 0.24 Å. Thus, we conclude that there are no significant differences between the monomers of the dimer or the dimers themselves upon binding either to 4,7-DOSA or 4-OSA (except for part of the lid near Arg 204 , described below), although the conformations of some side chains (mainly those located on the surface of the octamer) are occasionally different. The average temperature factors are 43.2 and 43.4 Å 2 for monomers A and B of the 4-OSA-containing complex and 30.2 and 31.2 Å 2 for monomers A and B of the 4,7-DOSA-containing complex. This indicates that the monomers in each complex have essentially the same degree of flexibility, although the crystals of the 4,7-DOSA complex have better internal order. The symmetry seen in E. coli PBGS dimers is in sharp contrast to the high resolution asymmetric dimer seen in P. aeruginosa PBGS (PDB code 1B4K) (20) and the less well resolved human PBGS, which contains extensive disorder (PDB code 1E51, unpublished structure).
The two E. coli PBGS structures presented here clarify the amino acid identity of position 133, which had previously been identified as a lysine (2) . The DNA sequence indicates Cys 133 and mass spectroscopy analysis of an AspN digest was obtained herein to demonstrate the existence of a cysteine in this position. Because Cys 133 is located on the surface of the protein, which has been purified and stored in the presence of mercaptoethanol, this residue appears as an adduct of ␤ME and cysteine (S,S-2-(hydroxyethyl)thiocysteine). The adduct was first reported in a V23C variant of staphylococcal nuclease (21) , and the current electron density is an excellent fit to this model.
Mechanism of Inhibition by 4-OSA and 4,7-DOSA-
The inhibitor molecules are clearly seen in the difference electron density maps in the area of the active site next to Lys 194 and Lys 246 in both monomers. In the case of 4,7-DOSA there are two covalent linkages between the protein and the inhibitor, and in the case of 4-OSA there is one covalent linkage. Fig. 5A illustrates an electron density map of 4-OSA bound to the enzyme, and Fig. 5B shows a comparison between the 4-OSAand 4,7-DOSA-inhibited proteins. In both cases C1-C5 of the inhibitor are bound with a Schiff base linkage between C4 and the ⑀-amino group of Lys 246 . In these cases, as well as in related PBGS structures with inhibitors bound in the P-side ALA binding pocket (PDB codes: 1B4E, 1B4K, 1EB3, 1YLV, 1I8J, 1GJP, 1H7N, 1H7P, 1H7R), the C1 carboxyl oxygens of the inhibitor make hydrogen bonds with Ser 272 and Tyr 311 . The positions of the C2 and C3 atoms of each inhibitor are well defined but not equivalent to each other. The variation in these positions mimics the reported alternate conformations of levulinic acid bound as the P-side Schiff base to yeast PBGS (PDB code 1H7N) (22) . This variation defines the limited spatial flexibility of P-side ALA and dictates that these atoms cannot reorient much in response to required hybridization changes at C4. The position of C1-C4 of 4-OSA more closely resembles that of the product porphobilinogen. As reported previously for the 1.9-Å structure of 4,7-DOSA-inhibited E. coli PBGS, the bond between C5 and C6 of the inhibitor has a distorted cis-configuration (torsion angle of C4 -C5-C6 -C7 is ϳ65°) to accommodate a second Schiff base linkage between C7 and the ⑀-amino group of Lys 194 . Because there is no Schiff base to Lys 194 in the 4-OSAinhibited enzyme, the conformation around the C5-C6 bond (torsion angle C4 -C5-C6 -C7 is ϳϪ88°) and the positions of C5-C10 of reacted 4-OSA are significantly different from those seen for 4,7-DOSA (Fig. 5B) . This suggests that A-side ALA has much greater positional flexibility than does P-side ALA. Positional flexibility is essential to accommodate the multiple hybridization changes required in the formation of porphobilinogen. In the case of both inhibitors, the A-side ALA half (C8 -C10) extends out toward the lid where it makes extensive hydrogen-bond linkages between the C10 carboxyl oxygens and arginine residue(s). However, the hydrogen-bonding pattern is not the same for the two inhibitors, as illustrated schematically in Fig. 6 . Unlike 4,7-DOSA, 4-OSA does not interact with Gln 219 through hydrogen bonds directly; instead it does so through a bridging water molecule. This is the same water molecule that forms similar bridging hydrogen bonds between Fig. 5B can be compared with recently published crystal structures of these inhibitors with yeast PBGS (PDB codes 1EB3 and 1GJP) (5). In these structures the A-side of the inhibitor is modeled such that the carboxyl groups of 4-OSA and 4,7-DOSA are in nearly the same position as each other. In the case of 4-OSA, we consider this interpretation questionable because Arg 220 (the counterpart of E. coli Arg 204 ) is shifted 2.6 Å away from the active site in a manner similar to what is found in the E. coli 4-OSA-inhibited PBGS structure. In the yeast structure, the dramatically shifted Arg 220 does not interact with the inhibitor or any other atoms except for two water molecules on the surface of the protein. In fact, 4-OSA of 1GJP is reported as "somewhat disordered," and the presented electron density map is completely lacking density for one of the A-site carboxyl oxygens. A more compelling reason to question the model for 4-OSA bound to yeast PBGS comes from a comparison of the yeast PBGS structure IGJP with the E. coli PBGS complex presented here. When one superimposes the 4-OSA-inhibited E. coli PBGS structure (where inhibitor was perfectly ordered) with 1GJP (superposition was based only on the protein parts of the complex), we find that our 4-OSA inhibitor makes exactly the same hydrogen bonds with the yeast enzyme, including Arg 220 in its new position, as in E. coli 4-OSA PBGS complex. In other words, the structure of 4-OSA as it is found in the complex with E. coli PBGS is energetically more favorable upon binding to the yeast enzyme than the one that was reported in the crystal structure of the complex of 4-OSA with yeast PBGS itself (5) . Taken together, these points shed doubt on the interpretation of the conformation of 4-OSA bound to yeast PBGS in structure 1GJP.
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4-OSA Bound to PBGS-The structures presented in
The PBGS-catalyzed Reaction Mechanism, Active Site Lid Motion, and Enzyme-bound Active Site Water-The PBGS-catalyzed reaction is illustrated in Fig. 1 . The first ALA to bind to PBGS is P-side ALA (18) . P-side ALA forms a Schiff base intermediate to an active site lysine (Lys 246 in E. coli PBGS) (23). Metals are not required for the binding or reactivity of P-side ALA (19) . Maintenance of the deprotonated Schiff baseforming lysine is accomplished by the neighboring basic residue (here Lys 194 ). As with all Schiff base-forming enzymes, one expects to be able to identify the residue that serves in the removal of the oxygen atom from the carbinolamine intermediate that precedes P-side Schiff base formation. This residue is not apparent in any PBGS crystal structures and has not been addressed in prior publications. The existing PBGS structures all place the P-side Schiff base in a very hydrophobic environment, part of which is composed of aromatic residues in the N-terminal portion of the active site lid (see Fig. 5 ). Because this Schiff base occurs for both 4-OSA and 4,7-DOSA, and the resulting water molecule is not observed near the P-side of the inhibitor, we conclude that this first water molecule must relocate prior to lid closure. One possible acceptor for the carbinolamine hydroxyl group would be the protonated Lys 194 in a rotomer conformation different from that which is observed in here. In this case the reaction would be as shown in Reaction I. 
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Alternatively, one may propose that the protonated base that dehydrates the P-side carbinolamine comes from an alternate configuration of the active site lid. The lid contains many conserved basic residues (see Fig. 3 ), which (as seen in the structures presented here) can interact with the A-side carboxyl group later in the reaction but may serve an additional function earlier.
The second ALA to bind to PBGS is A-side ALA. For those PBGS that use a catalytic Zn 2ϩ , the metal ion is required for A-side ALA binding and reactivity (19) . The crystal structures of 4,7-DOSA-and 4-OSA-inhibited PBGS support the mechanistic hypothesis that the keto oxygen removed from C4 of A-side ALA (C7 of the inhibitors) ends up coordinated to the catalytic Zn 2ϩ (3). We have proposed that A-side ALA binds as a bidentate Zn 2ϩ ligand through the C4 keto oxygen and the C5 amino group (24) . Molecular modeling studies indicate that this complex fits into the A-side ALA binding pocket and takes advantage of the unique flexibility of Zn 2ϩ to accommodate various coordination numbers and geometries (25) . The coordination environment of this Zn 2ϩ is unusual for a catalytic Zn 2ϩ in that it contains three cysteine ligands that derive from a short stretch of 11 amino acids. The structures presented here indicate that the Zn 2ϩ -bound water molecule is appropriately positioned to have derived from the keto group analogous to that of A-side ALA.
Based on the extensive hydrogen-bonding interactions between the A-side carboxylic acid group of 4-OSA and 4,7-DOSA and the active site lid residues, we conclude that A-side ALA binding necessitates the ordering or reordering of the active site lid. The PBGS-catalyzed reaction involves significant hybridization changes at multiple carbon centers (see Fig. 1 ). As described above, large translational motion is not possible for the propionyl side chain of P-side ALA. For A-side ALA, the C5 amino-containing portion appears relatively fixed through interaction with the catalytic Zn 2ϩ . This is apparent from prior 13 C and 15 N NMR data (26) and from the observation that the amino group of the product porphobilinogen is chelated to the Zn 2ϩ in the unpublished human PBGS structure 1E51 and in the complex of E. coli PBGS with porphobilinogen. 2 Thus, to accommodate the significant hybridization changes, particularly at C3 of A-side ALA, the acetyl side chain must experience substantial mobility throughout the course of the reaction. One significant contribution of the current structure is the visualization of a different orientation for the inhibitor atoms C6 -C10 analogous to C1-C5 of the A-side ALA. We propose that the observed multiple hydrogen bonds between the C10 carboxyl and Arg 204 , Arg 215 , Gln 219 , and associated water molecules change conformation to accommodate various positions of C1 and C2 of A-side ALA during the course of the PBGScatalyzed reaction.
A particularly vexing question in understanding the PBGScatalyzed reaction mechanism has been the identification of the residues that serve as acceptors for the four protons and two oxygen atoms lost in the condensation of two ALA molecules to porphobilinogen. The contribution of these crystal structures to identifying the oxygen acceptors is discussed above. The proton acceptor(s) for the deprotonations of the amino group and C5 of P-side ALA appear to be the two active site lysine residues as discussed previously (2) . Remarkably, there are no amino acids positioned to be the proton acceptors at A-side ALA. Rather, comparison of these and other PBGS structures shows a bath of highly conserved water molecules adjacent to and including the Zn 2ϩ -bound water that initially derives from C4 of A-side ALA. These water molecules are illustrated in Fig. 5A . Their positions are highly conserved, and they are isolated from bulk solvent. These water molecules appear to be the only possible acceptors for the protons that must be lost from A-side ALA. The implication of water as the proton acceptor in the formation of an enamine from an imine, akin to the removal of the first proton from C3 of A-side ALA, is not without precedent. Analogous chemistry has recently been implicated in the mechanism of D-2-deoxyribose-5-phosphate aldolase (27) .
In summary, the PBGS-catalyzed reaction mechanism has been a subject of debate for more than three decades. In fact, many different detailed reaction mechanisms have been illustrated in the literature (e.g. Refs. 2, 4 -6, 18, 28 -30), most of which do not include a role for one or more essential metal ions. Basic features such as the order of bond-making and bondbreaking reactions in the PBGS-catalyzed reaction remains uncertain and may not be conserved for all of the PBGS from different species. The current structures do not resolve these uncertainties. However, the new structures of 4-OSA-and 4,7-DOSA-inhibited PBGS help identify the acceptor groups for the atoms that are abstracted from the substrate molecules. They suggest that enzyme-bound active site water molecules play pivotal roles in the PBGS-catalyzed reaction and that there is a mechanistic importance to fluctuations between multiple conformations of the active site lid.
